HomeAI · summaries
Storia in 8 fonti
CDSCO clears recombinant live attenuated dengue vaccine for ages 4 to 60 years
India's CDSCO has approved the first dengue vaccine, Qdenga, for individuals aged 4 to 60 after rigorous evaluation.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
economictimes.indiatimes.com
Takeda Biopharmaceuticals gets DCGI nod for dengue vaccine QDENGA
Takeda Biopharmaceuticals India has received market authorization for its dengue vaccine QDENGA. This vaccine is now approved for individuals aged four to sixty years old. QDENGA…
- ·
newsbytesapp.com
India's 1st ever dengue vaccine has come from Japan
Japanese drugmaker Takeda's QDENGA has become India's first approved dengue vaccine, offering protection against all four virus serotypes without requiring pre-vaccination testing.
